Friday, January 23, 2026
Friday, January 23, 2026
HomeBREAKING NEWSRussia’s mRNA Cancer Vaccine Enteromix Shows 100% Efficacy in Clinical Trials

Russia’s mRNA Cancer Vaccine Enteromix Shows 100% Efficacy in Clinical Trials

Published on

In what scientists are calling a potential medical breakthrough, Russia’s mRNA-based cancer vaccine Enteromix has demonstrated 100% efficacy and safety in clinical trials. The vaccine, which targets and destroys cancer cells while shrinking large tumours, is now awaiting final approval from the Ministry of Health before being made available to the public, according to RT India.

Developed with technology similar to COVID-19 vaccines, Enteromix works by training the immune system to recognize and eliminate cancer cells. Remarkably, the vaccine is personalized for every patient, ensuring precise treatment.

Russia’s Enteromix Cancer Vaccine Shows 100% Success in Trials

Unlike chemotherapy or radiation, Enteromix did not cause any serious side effects, with patients reportedly tolerating the vaccine well. Earlier clinical trials involved 48 volunteers, overseen by Russia’s Ministry of Health’s National Medical Research Radiology Centre in collaboration with the Engelhardt Institute of Molecular Biology (EIMB) of the Russian Academy of Sciences (RAS).

Enteromix Unveiled at St. Petersburg Economic Forum

The clinical trial was officially announced at the St. Petersburg International Economic Forum (SPIEF 2025), held from June 18–21. Organized by the Roscongress agency under the Russian President’s office, the event highlighted Russia’s progress in biotechnology and advanced medical research.

How Enteromix Works Against Cancer

According to a MedPath report, Enteromix uses four harmless viruses to attack and destroy cancerous tumours, while simultaneously boosting the immune system to fight the disease. After years of testing, results have shown it can slow tumour growth and, in some cases, completely eradicate cancer cells.

Awaiting Final Approval Before Global Rollout

With trials successfully completed, the only step remaining is regulatory clearance from the Russian Ministry of Health. If approved, Enteromix could become the world’s first personalized mRNA cancer vaccine, offering new hope to millions of patients worldwide.

Get Latest News Live on MTIMES along with Breaking News and Top Headlines, Political News and around The World.

You May Like

Trending Searches Today |

Congress Criticises Government’s GST Reform, Says True GST 2.0 Reform in India Still Awaited

SSC CGL New Exam Date 2025 Out: Tier 1 Scheduled from 12th to 26th September

OSSSC Re-Conducts Preliminary Exam 2023: RI, ARI, Amin, Supervisor and SFS Posts from October 8

56th GST Council Meeting: Big GST Rate Cuts Announced, Focus on Common Man and Key Sectors

Vladimir Putin Backs India and China: “You Cannot Talk to India, China Like That” Amid Trump’s Tariff Pressure

Undersea Cable Cuts in Red Sea Disrupt Internet Across Asia and Middle East

Bestseller #1
  • DYNAMIC ISLAND COMES TO IPHONE 15 — Dynamic Island bubbles up alerts and Live Activities — so you don’t miss them while …
  • INNOVATIVE DESIGN — iPhone 15 features a durable color-infused glass and aluminum design. It’s splash, water, and dust r…
  • 48MP MAIN CAMERA WITH 2X TELEPHOTO — The 48MP Main camera shoots in super-high resolution. So it’s easier than ever to t…
₹59,700
Bestseller #2
  • 15 cm (6.1-inch) Super Retina XDR display
  • Cinematic mode adds shallow depth of field and shifts focus automatically in your videos
  • Advanced dual-camera system with 12MP Wide and Ultra Wide cameras; Photographic Styles, Smart HDR 4, Night mode, 4K Dolb…
₹60,900
Bestseller #3
  • BUILT FOR APPLE INTELLIGENCE — Apple Intelligence is the personal intelligence system that helps you write, express your…
  • TAKE TOTAL CAMERA CONTROL — Camera Control gives you an easier way to quickly access camera tools, like zoom or depth of…
  • GET FURTHER AND CLOSER — The improved Ultra Wide camera with autofocus lets you take incredibly detailed macro photos an…
₹83,500

Share Market

Indian Stock Market Today Closes Sensex 398 Points, Nifty Near 25,300

Indian stock market today closed higher as Sensex and Nifty gained on global cues and India–U.S. trade optimism. Get key levels now.

Indian Stock Market Crash January 20: Sensex downs 1,065 Points, Nifty Below 25,250

Indian stock market crash January 20 sees Sensex plunge over 1,000 points and Nifty slip below 25,250 amid broad selloff. Read analysis.

More like this

Indian Stock Market Today Closes Sensex 398 Points, Nifty Near 25,300

Indian stock market today closed higher as Sensex and Nifty gained on global cues and India–U.S. trade optimism. Get key levels now.

India Protests Vandalism of Embassy in Croatia, Demands Accountability

India protests vandalism of its embassy in Croatia and urges action against perpetrators. Read MEA’s strong response ahead of EU visit.

India Spy Satellites Expansion Planned After Surveillance Gaps Revealed

India spy satellites upgrade planned as over 50 new satellites with night-time imaging to be launched. Read how it boosts surveillance.